PE-backed AskBio buys Synpromics
AskBio, backed by private equity firms TPG Capital and Vida Ventures, has bolted on gene therapy developer Synpromics.
More on Portfolio management
InfraVia's Celeste acquires PE-backed VTX Telecom
Exiting their stakes, Iris and Siparex first invested in the telecoms service in 1999 and 2005 respectively
PE-backed Helgstrand Dressage merges with Ludger Beerbaum Stables
Carlyle-backed Hurst Point acquires Hawksmoor
Hurst Point Group was established in 2019 to facilitate investment by Carlyle in UK wealth management
ArchiMed-backed Bomi bolts on Deco Pharma
With this add-on, the company plans to further strengthen its presence across southern Europe
Latest News
Eurazeo raises €2.8bn in 2020
Amount includes the capital raised by Eurazeo Growth III, which has now collected more than €500m
ICG hires Bridge Valley's life sciences investment team
Allan Marchington, who will become head of ICG life sciences, says the team has a strong pipeline
Pantheon promotes four to partner
Petra Bukovec is a member of Pantheon's secondaries team and is based in London
Eight Roads promotes Cornet to partner
Principal Lucile Cornet joined Eight Roads Ventures as an associate in 2016